Načítá se...
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Middle East Respiratory Syndrome (MERS) is a highly lethal pulmonary infection caused by a previously unidentified coronavirus (CoV), likely transmitted to humans by infected camels. There is no licensed vaccine or antiviral for MERS, therefore new prophylactic and therapeutic strategies to combat h...
Uloženo v:
Vydáno v: | Proc Natl Acad Sci U S A |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
National Academy of Sciences
2015
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4547275/ https://ncbi.nlm.nih.gov/pubmed/26216974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1510199112 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|